Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer
Changqing Zeng(Henan Academy of Sciences), Robert H. Mach(California University of Pennsylvania)
Cited by 35
Related Papers
Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site
|Nature Communications|2011|296
Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex
|Scientific Reports|2018|146
Sigma-2 ligands induce tumour cell death by multiple signalling pathways
|British Journal of Cancer|2012|97
A multivalent mRNA-LNP vaccine protects against <i>Clostridioides difficile</i> infection
|Science|2024|73
Breast Cancer<sup>18</sup>F-ISO-1 Uptake as a Marker of Proliferation Status
|Journal of Nuclear Medicine|2019|38